Actively Recruiting
Evaluating Liver Stiffness Measurement by FibroScan to Diagnose Elevated Central Venous Pressure in Heart Failure Patients
Led by Echosens · Updated on 2026-09-23
149
Participants Needed
7
Research Sites
2 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating a non-invasive way to assess elevated central venous pressure CVP in patients with heart failure HF. This study focuses on using Liver Stiffness Measurement LSM by FibroScan, which may offer a safer alternative to the current invasive catheter-based methods that carry risks and are not suitable for all patients. The study aims to evaluate the accuracy of LSM using a specific cutoff value to detect elevated CVP, which is an important marker of congestion in HF. Participants will undergo several assessments on the same day, including a FibroScan examination to measure liver stiffness, right-sided heart catheterization to directly measure CVP, echocardiography to assess heart function, and blood tests to check organ function. These procedures will be performed once at the start of the study to compare LSM results with invasive CVP measurements and other clinical markers. During the study, participants will be closely evaluated through imaging and laboratory tests to measure how well LSM identifies elevated CVP compared to the standard invasive method. Researchers will analyze correlations between LSM, echocardiographic parameters, blood biomarkers, and clinical factors. The main goal is to determine the sensitivity and specificity of LSM for diagnosing elevated CVP, with the entire assessment occurring on a single study day.
CONDITIONS
Brief Title
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Research Team
C
CAROLE MEILLEROUX, PharmD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here